Observational Study
Copyright ©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 592-601
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.592
Table 3 Univariate and multivariate analysis of survivors and non-survivors at 28-d
Variables
Survivors (n = 77)
Non-survivors (n = 42)
Univariate
Multivariate
Age (yr, mean ± SD)41 ± 2140 ± 220.73-
Males, n (%) 69 (86.9%)36 (85.7%)0.41-
Hb (gm/dL)8.3 (4-14)8.4 (3.4-14)0.838-
TLC (× 103/mm3)11 (2.5-37)17.4 (2-39)0.001-
Platelet count (× 109/L)114.6 (100-200)130 (60-220)0.520-
Bilirubin (mg/dL)4.2 (0.5-30)15.7 (0.2-46)0.001< 0.001
INR1.8 (1-3.7)2.1 (1.2-3.8)0.006-
Albumin (gm/dL)2.4 (1-3.7)2.4 (1.8-3.9)0.689-
Sodium (mEq/L)135 (116-164)131 (120-146)0.336-
HE, n3237< 0.001< 0.01